Bioregenx (BRGX) Long-Term Investments (2021 - 2023)

Bioregenx has reported Long-Term Investments for 3 years, with the latest figure at $100.0 in Q4 2023.

• For the quarter ending Q4 2023, Long-Term Investments fell 99.52% year-over-year to $100.0; the trailing twelve-month figure through Dec 2023 stood at $100.0 (down 99.52% YoY), and the FY2023 full-year result was $100.0, down 99.52% from the prior year.
• Long-Term Investments for Q4 2023 stood at $100.0, down from $200.0 in the prior quarter.
• The five-year high for Long-Term Investments was $60000.0 in Q4 2021, with the low at $100.0 in Q4 2023.
• Average Long-Term Investments over 3 years is $29050.0, with a median of $31500.0 recorded in 2022.
• Year-over-year, Long-Term Investments slumped 65.0% in 2022 and sank 99.52% in 2023.
• Tracing BRGX's Long-Term Investments over 3 years: stood at $60000.0 in 2021, then tumbled by 65.0% to $21000.0 in 2022, then slumped by 99.52% to $100.0 in 2023.
• The last three Long-Term Investments figures came in at $100.0 (Q4 2023), $200.0 (Q3 2023), and $51000.0 (Q2 2023), per Business Quant data.

Peer Comparison